FATE
FATE THERAPEUTICS INC
Nasdaq Biological Products, (No Diagnostic Substances) Non-accelerated filer
Smaller reporting company

Key Financials

Operating Income
$-147704000
↑ 29.8%
Net Income
$-136315000
↑ 26.8%
Revenue
$6.6M
↓ 51.2%
EPS (Diluted)
$-1.15
↑ 29.9%
Total Assets
$318.9M
↓ 27.6%
Shareholders' Equity
$207.2M
↓ 35.0%
Cash & Equivalents
$46.6M
↑ 29.3%
Long-term Debt
$18.5M
↓ 4.3%

Recent SEC Filings

Form Type Filed Date Link
8-K 9/28/2026 View on SEC
S-8 8/13/2026 View on SEC
10-Q 8/13/2026 View on SEC
8-K 8/13/2026 View on SEC
4 8/5/2026 View on SEC
4 8/5/2026 View on SEC
144 8/4/2026 View on SEC
144 8/4/2026 View on SEC
SCHEDULE 13G/A 7/8/2026 View on SEC
4 6/15/2026 View on SEC

Company Information

Field Value
Ticker FATE
Company Name FATE THERAPEUTICS INC
CIK 1434316
Sector Biological Products, (No Diagnostic Substances)
Industry Non-accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
Phone 858.875.1803